IGF1 and neoplasm: Protein restriction reduced insulin-like growth factor 1 (IGF-1) in blood and thus inhibited the IGF-1/IGFR1/PI3K/AKT/mTORC1 axis in tumor cells, TAMs, and Tregs, activating anti-tumor T cells [101, 104, 105].